Heart Valve Diseases Clinical Trial
— INCREASEOfficial title:
Interdisciplinary and Cross-sectoral Perioperative Care Model in the Cardiac Surgery: Implementation in the Setting of Minimally-invasive Heart Valve Surgery (INCREASE)
Verified date | December 2023 |
Source | Universitätsklinikum Hamburg-Eppendorf |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Valvular heart diseases are among the most common cardiac pathologies in adult patients in Germany. Currently, the process of care before, during and after heart valve surgery does not follow a standardized and interdisciplinary optimal approach. An approach already established in other surgical disciplines is the Enhanced Recovery After Surgery (ERAS) protocol, which aims at optimizing the recovery process of patients. Within the INCREASE study, a care process inspired by the ERAS protocol will be established at the University Heart and Vascular Center (UHZ) of the University Medical Center Hamburg-Eppendorf (UKE) and the University Medical Center Augsburg (UKA). Executing the study at two facilities in different regions in Germany will help to demonstrate transferability of the process of care. The effectiveness of this process compared to the current treatment approach will be investigated in a randomized controlled trial. A total of 186 patients will be allocated by chance either to the intervention group (ERAS protocol) or the control group (treatment as usual). Patients in the intervention group will receive an optimized interdisciplinary care protocol including medical, nursing, physiotherapeutical and psychotherapeutical interventions. Measurements of effectiveness are the number of hospitalized days (due to cardiac causes) within one year and the physical condition of the patient as measured by the 6-minute walk test (6MWT) on the day of discharge.
Status | Active, not recruiting |
Enrollment | 201 |
Est. completion date | June 2024 |
Est. primary completion date | February 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Indication for elective minimally invasive (open) aortic or mitral valve surgery - Patient's ability to understand the nature and extent of the individual's requirements for participation in the new care setting - Classification of the patient as "FIT" or "Pre-FRAIL" using the LUCAS functional index (frailty index) (Dapp et al. 2012) Exclusion Criteria: - Limited life expectancy less than one year (e.g., advanced tumor disease) - Urgent or emergency interventions - Severe chronic obstructive pulmonary disease (GOLD III or IV) - Dialysis-dependant renal failure - Advanced liver cirrhosis (Child stages B + C) - Severe comorbidities or psychosocial reasons that militate against participation or do not allow for written informed consent (e. g., residual neurological impairment after prior stroke, major restrictions of mobility, neuropsychological disorders, depressive disorder, substance-related addictive disorders) - Lack of a social environment that can provide supportive patient care - Previous cardiac surgery (i.e., relative contraindication for minimally invasive technique) |
Country | Name | City | State |
---|---|---|---|
Germany | Universitätsklinikum Augsburg | Augsburg | Bavaria |
Germany | Universitätsklinikum Hamburg-Eppendorf | Hamburg |
Lead Sponsor | Collaborator |
---|---|
Universitätsklinikum Hamburg-Eppendorf | BARMER, University Hospital Augsburg |
Germany,
Klotz SGR, Ketels G, Behrendt CA, Konig HH, Kohlmann S, Lowe B, Petersen J, Stock S, Vettorazzi E, Zapf A, Zastrow I, Zollner C, Reichenspurner H, Girdauskas E. Interdisciplinary and cross-sectoral perioperative care model in cardiac surgery: implementation in the setting of minimally invasive heart valve surgery (INCREASE)-study protocol for a randomized controlled trial. Trials. 2022 Jun 23;23(1):528. doi: 10.1186/s13063-022-06455-x. Erratum In: Trials. 2022 Oct 5;23(1):853. — View Citation
Kubitz JC, Schulte-Uentrop L, Zoellner C, Lemke M, Messner-Schmitt A, Kalbacher D, Sill B, Reichenspurner H, Koell B, Girdauskas E. Establishment of an enhanced recovery after surgery protocol in minimally invasive heart valve surgery. PLoS One. 2020 Apr 9;15(4):e0231378. doi: 10.1371/journal.pone.0231378. eCollection 2020. — View Citation
Petersen J, Kloth B, Konertz J, Kubitz J, Schulte-Uentrop L, Ketels G, Reichenspurner H, Girdauskas E. Economic impact of enhanced recovery after surgery protocol in minimally invasive cardiac surgery. BMC Health Serv Res. 2021 Mar 20;21(1):254. doi: 10.1186/s12913-021-06218-5. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | European Health Literacy Questionnaire (HLS-EU-Q16) | health literacy: 16 items, min 16, max 64, higher scores indicating lower health literacy | day of discharge (approx. 5 - 10 days after operation) | |
Other | European Health Literacy Questionnaire (HLS-EU-Q16) | health literacy: 16 items, min 16, max 64, higher scores indicating lower health literacy | twelve months | |
Other | Brief Illnness Perception Questionnaire (BIPQ) | individual concept of illness; 8 items, min 0, max 80, higher scores indicating worse illness perception | day of discharge (approx. 5 - 10 days after operation) | |
Other | Brief Illnness Perception Questionnaire (BIPQ) | individual concept of illness; 8 items, min 0, max 80, higher scores indicating worse illness perception | twelve months | |
Other | Treatment Expectation Questionnaire (TEX-Q) | treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment | day of discharge (approx. 5 - 10 days after operation) | |
Other | Treatment Expectation Questionnaire (TEX-Q) | treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment | three months | |
Other | Treatment Expectation Questionnaire (TEX-Q) | treatment expectations; 15 items, min 0, max 150, higher scores indicating higher expectations of effects of the treatment | twelve months | |
Other | Patient Health Questionnaire-9 (PHQ-9) | depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms | day of discharge (approx. 5 - 10 days after operation) | |
Other | Patient Health Questionnaire-9 (PHQ-9) | depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms | three months | |
Other | Patient Health Questionnaire-9 (PHQ-9) | depressive symptoms; 9 items, min 0, max 27, higher scores indicating higher depressive symptoms | twelve months | |
Other | Generalized Anxiety Disorder-2 (GAD-2) | anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms | day of discharge (approx. 5 - 10 days after operation) | |
Other | Generalized Anxiety Disorder-2 (GAD-2) | anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms | three months | |
Other | Generalized Anxiety Disorder-2 (GAD-2) | anxiety symptoms; 2 items, min 0, max 6, higher scores indicating higher anxiety symptoms | twelve months | |
Other | Cardiac Anxiety Questionnaire (CAQ) | cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety | day of discharge (approx. 5 - 10 days after operation) | |
Other | Cardiac Anxiety Questionnaire (CAQ) | cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety | three months | |
Other | Cardiac Anxiety Questionnaire (CAQ) | cardiac anxiety; 17 items, min 0, max 68, higher scores indicating higher cardiac anxiety | twelve months | |
Other | Life Orientation Test - revised (LOT-R) | optimism; 10 items, min 0, max 24, higher scores indicating higher optimism | day of discharge (approx. 5 - 10 days after operation) | |
Other | Somatic Symptom Scale-8 (SSS-8) | somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden | day of discharge (approx. 5 - 10 days after operation) | |
Other | Somatic Symptom Scale-8 (SSS-8) | somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden | three months | |
Other | Somatic Symptom Scale-8 (SSS-8) | somatic symptom burden; 8 items, min 0, max 32, higher scores indicating higher somatic symptom burden | twelve months | |
Other | Somatic Symptom Disorder - B Criteria Scale (SSD-12) | coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms | day of discharge (approx. 5 - 10 days after operation) | |
Other | Somatic Symptom Disorder - B Criteria Scale (SSD-12) | coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms | three months | |
Other | Somatic Symptom Disorder - B Criteria Scale (SSD-12) | coping with somatic symptoms; 12 items, min 0, max 48, higher scores indicating worse coping with somatic symptoms | twelve months | |
Other | International Physical Activity Questionnaire Short Form (IPAQ) | level of physical activity | day of discharge (approx. 5 - 10 days after operation) | |
Other | International Physical Activity Questionnaire Short Form (IPAQ) | level of physical activity | twelve months | |
Other | Hand Dynamometer | hand grip strength | day of discharge (approx. 5 - 10 days after operation) | |
Other | Hand Dynamometer | hand grip strength | twelve months | |
Other | 1 Minute Sit to Stand Test (1STS) | physical capacity expressed with the number of repetitions | day of discharge (approx. 5 - 10 days after operation) | |
Other | 1 Minute Sit to Stand Test (1STS) | physical capacity expressed with the number of repetitions | twelve months | |
Other | Timed Up and Go (TUG) | physical capacity expressed with the duration in seconds | day of discharge (approx. 5 - 10 days after operation) | |
Other | Timed Up and Go (TUG) | physical capacity expressed with the duration in seconds | twelve months | |
Other | Six Minute Walk Test | physical capacity expressed with the walking distance in meters | twelve months | |
Other | Goal Attainment Scale (GAS) | level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected | day of discharge (approx. 5 - 10 days after operation) | |
Other | Readiness for Hospital Discharge Scale (RHDS) | readiness for hospital discharge; 9 items, min 0, max 36, higher scores indicating higher readniss to discharge | day of discharge (approx. 5 - 10 days after operation) | |
Other | 5-level EQ-5D Health-related Quality of Life Questionnaire (EQ-5D-5L) | health-related quality of life; 6 items, interpretation following an algorythm between 1 (best possible health condition) and <0 (worst possible health condition) | three months | |
Other | 5-level EQ-5D Health-related Quality of Life Questionnaire (EQ-5D-5L) | health-related quality of life; 6 items, interpretation following an algorythm between 1 (best possible health condition) and <0 (worst possible health condition) | twelve months | |
Other | Questionnaire for Health-Related Resource Use in an Elderly Population (FIMA) | use of health care services; 11 items collecting numbers of health care services and days of usage, min 0, higher scores indicating higher usage of services | twelve months | |
Primary | Hospitalization | number of hospitalized days due to cardiac reasons | twelve months | |
Primary | Six Minute Walk Test | physical capacity expressed with the walking distance in meters | day of discharge (approx. 5 - 10 days after operation) | |
Secondary | Goal Attainment Scale (GAS) | level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected | three months | |
Secondary | Goal Attainment Scale (GAS) | level of attainment of individual goal: +2 = much more than expected, +1 = somewhat more than expected, 0 = goal achieved than expected, -1 = somewhat less than expected, -2 = much less than expected | twelve months | |
Secondary | HeartQoL | health-related quality of life; 14 items, min 0, max 42, higher scores indicating better health-related quality of life | three months | |
Secondary | HeartQoL | health-related quality of life; 14 items, min 0, max 42, higher scores indicating better health-related quality of life | twelve months | |
Secondary | Costs | direct costs in € associated with the operative procedure and the initial hospitalization using diagnosis related groups as classification system, in which diagnoses and treatments are valued according to their necessary economical expenditure | up to 10 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02865798 -
China Senile Valvular Heart Disease Cohort Study
|
N/A | |
Completed |
NCT02249000 -
BIOVALVE - I / II Clincial Investigation
|
N/A | |
Completed |
NCT02297334 -
Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery
|
N/A | |
Completed |
NCT01591018 -
SONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEry
|
Phase 3 | |
Completed |
NCT01428947 -
Does Coronary Angiography Cause Cognitive Dysfunction?
|
N/A | |
Recruiting |
NCT01231776 -
Acupuncture Improves Sleep in Patients Undergoing Cardiopulmonary Bypass
|
N/A | |
Terminated |
NCT01116037 -
ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study
|
N/A | |
Completed |
NCT00371891 -
Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)
|
Phase 4 | |
Terminated |
NCT03632967 -
Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System
|
N/A | |
Recruiting |
NCT05728047 -
Evaluation of Systemic Microcirculation of Patients Undergoing Heart Valve Surgery
|
||
Not yet recruiting |
NCT05539261 -
Research on Neurological Prognosis of Patients Undergoing Heart Valve Surgery
|
||
Completed |
NCT05479968 -
Spectroscopic Assessment of Intramyocardial Oxygen Saturation Feasibility During Open-heart Surgery
|
||
Completed |
NCT03527381 -
Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT03664102 -
Automated Fastener Device Versus Manually Tied Knot in MiAVR
|
||
Recruiting |
NCT06084091 -
Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery
|
||
Completed |
NCT05836467 -
Is Myocardial Revascularization Really Necessary in Patients With ≥50-70% Coronary Stenosis Undergoing Valvular Surgery?
|
||
Recruiting |
NCT05933083 -
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
|
N/A | |
Recruiting |
NCT04445012 -
Cardiovascular Acoustics and an Intelligent Stethoscope
|
||
Active, not recruiting |
NCT02732691 -
JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study
|
N/A | |
Completed |
NCT02981953 -
TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System
|
N/A |